Abiopharma

New Form 6-K - Haleon plc Filed: 2025-06-27 AccNo: 0001654954-25-007462 Size: 28 KB

Eton Pharmaceuticals Announces Addition to Russell2000® and Russell 3000® Indexes

Pharvaris Announces Clinical Trial Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2025 US HAEA National Summit

New Form 6-K - GSK plc Filed: 2025-06-27 AccNo: 0001654954-25-007457 Size: 2 MB

NUTEX HEALTH ANNOUNCES THAT IT HAS FILED A SUPPLEMENT TO ITS PROXY STATEMENT

IFF 發佈《2024 Do More Good Report》彰顯可持續發展與創新成果

New Form 4 - PRECISION BIOSCIENCES INC Filed: 2025-06-27 AccNo: 0001628280-25-033199 Size: 5 KB

New Form 4 - SeaStar Medical Holding Corp Filed: 2025-06-27 AccNo: 0001213900-25-058569 Size: 5 KB

New Form EFFECT - Ontrak, Inc. Filed: 2025-06-26 AccNo: 9999999995-25-002041 Size: 2 KB

New Form EFFECT - Connect Biopharma Holdings Ltd Filed: 2025-06-26 AccNo: 9999999995-25-002040 Size: 1 KB

New Form EFFECT - 180 Life Sciences Corp. Filed: 2025-06-26 AccNo: 9999999995-25-002043 Size: 1 KB

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

FDA approve PURIFIED WATER

FDA approve METHADONE HYDROCHLORIDE

FDA approve METOPROLOL SUCCINATE